Market Cap: $250.47M
AI
Abeona Therapeutics Inc.
ABEO
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $250.47M
Abeona Therapeutics: Advancing Gene Therapy in Rare Diseases Abeona Therapeutics, a leader in gene and cell therapy focused on rare genetic diseases, continues to make strides in the development of in…
Abeona Therapeutics Sets Focus on Advancements in Gene Therapy Abeona Therapeutics, a leading player in the field of gene therapy, is currently engaged in significant developments that hold promise fo…
Abeona Therapeutics: Navigating the Evolving Landscape of Gene Therapy Abeona Therapeutics stands at the forefront of the gene therapy industry as it continues to focus on innovative treatments for ra…
Abeona Therapeutics Gears Up for Key Earnings Release Amidst Pipeline Advancements Abeona Therapeutics, a biotechnology company specializing in gene and cell therapies for life-threatening diseases, i…
Abeona Therapeutics Gears Up for Key Earnings Announcement Amidst Clinical Advancements Abeona Therapeutics is poised to disclose its quarterly earnings on November 12, 2025, an event that carries sig…
Abeona Therapeutics: A New Chapter in Gene Therapy Approvals Abeona Therapeutics Inc. celebrates a significant milestone with the recent approval of its gene therapy by the Food and Drug Administratio…
Abeona Therapeutics Achieves Landmark FDA Approval for Gene Therapy in Rare Skin Disorder Abeona Therapeutics Inc. celebrates a significant milestone with the U.S. Food and Drug Administration (FDA) g…
Abeona Therapeutics Secures FDA Approval for Groundbreaking Gene Therapy Abeona Therapeutics Inc. achieves a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval fo…